{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:37:43Z","timestamp":1784201863006,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.taap.2005.11.013","type":"journal-article","created":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T14:14:55Z","timestamp":1138112095000},"page":"61-68","source":"Crossref","is-referenced-by-count":5,"title":["Possible mechanism for species difference on the toxicity of pivalic acid between dogs and rats"],"prefix":"10.1016","volume":"214","author":[{"given":"Toshiro","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2005.11.013_bib1","series-title":"l-Carnitine and its Role in Medicine: From Function to Therapy","first-page":"21","article-title":"Carnitine transport","author":"Beass","year":"1992"},{"key":"10.1016\/j.taap.2005.11.013_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0009-9236(02)17636-3","article-title":"Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil","volume":"73","author":"Brass","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2005.11.013_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0026-0495(95)90058-6","article-title":"Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency","volume":"44","author":"Broderick","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.taap.2005.11.013_bib4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1139\/cjpp-79-10-892","article-title":"Short-term carnitine deficiency does not alter aerobic rat heart function but depresses reperfusion recovery after ischemia","volume":"79","author":"Broderick","year":"2001","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.taap.2005.11.013_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davis","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2005.11.013_bib6","first-page":"16","article-title":"Metabolic disposition of [14C]Sodium pivalate in dogs","volume":"26","author":"Esumi","year":"1995","journal-title":"Iyakuhin Kenkyu"},{"issue":"Suppl. 22","key":"10.1016\/j.taap.2005.11.013_bib7","first-page":"S116","article-title":"Carnitine metabolism in chronic renal failure","volume":"32","author":"Guarnieri","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2005.11.013_bib8","first-page":"1129","article-title":"Oral 3-month repeated-dose toxicity study of S-1108, a new ester-type oral cephem antibiotic, in rats","volume":"24","author":"Itoh","year":"1993","journal-title":"Iyakuhin Kenkyu"},{"key":"10.1016\/j.taap.2005.11.013_bib9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0024-3205(78)90499-X","article-title":"Species differences in the metabolism of benzoic acid by isolated hepatocytes and kidney tube fragments","volume":"23","author":"Kao","year":"1978","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2005.11.013_bib10","first-page":"1175","article-title":"Three-month toxicity study of S-1108, a new ester-type oral cephem antibiotic, and its main metabolites in rats","volume":"24","author":"Kashima","year":"1993","journal-title":"Iyakuhin Kenkyu"},{"key":"10.1016\/j.taap.2005.11.013_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0006-2952(95)02399-2","article-title":"Participation of a medium chain acyl-CoA synthetase in glycine conjugation of the benzoic acid derivatives with the electron-donating groups","volume":"51","author":"Kasuya","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2005.11.013_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0003-2697(83)90323-8","article-title":"A radioisotopic exchange method for quantitation of short-chain (acid-soluble) acylcarnitine","volume":"134","author":"Kerner","year":"1983","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2005.11.013_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3999\/jscpt.24.73","article-title":"Carnitine concentration in plasma, tissue and urine after successive administration of S-1108 and effect of carnitine supplementation","volume":"24","author":"Mizojiri","year":"1993","journal-title":"Jpn. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2005.11.013_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1128\/AAC.39.7.1445","article-title":"Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dos","volume":"39","author":"Mizojiri","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2005.11.013_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/AAC.36.4.762","article-title":"Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores","volume":"36","author":"Nakashima","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2005.11.013_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/jf60215a010","article-title":"Environmental degradation of the miticide cycloprate (hexadecyl cyclopropanecarboxylate): 4. Beagle dog metabolism","volume":"26","author":"Quistad","year":"1978","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2005.11.013_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-4165(94)00129-L","article-title":"Formation of pivaloyl carnitine in heart and brawn adipose tissue in the rat","volume":"1243","author":"Quy","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2005.11.013_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0041-008X(05)80012-2","article-title":"Metabolic effects of pivalate in isolated rat hepatocytes","volume":"110","author":"Ruff","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2005.11.013_bib19","series-title":"Method of Subcellular Fractionation","first-page":"141","article-title":"Mitochondria and related structure","author":"Sone","year":"1972"},{"key":"10.1016\/j.taap.2005.11.013_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.35.7.1041","article-title":"Carnitine deficiency, organic acidemias, and reye's syndrome","volume":"35","author":"Stumpf","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2005.11.013_bib21","first-page":"1198","article-title":"Three-month intravenous toxicity study of main metabolites of S-1108, a new ester-type oral cephem antibiotic, in dogs","volume":"24","author":"Suzuki","year":"1993","journal-title":"Iyakuhin Kenkyu"},{"key":"10.1016\/j.taap.2005.11.013_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.36.4.757","article-title":"Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans","volume":"36","author":"Totsuka","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 22","key":"10.1016\/j.taap.2005.11.013_bib23","first-page":"S132","article-title":"Carnitine metabolism in patients with chronic renal failure: effect of l-carnitine supplementation","volume":"32","author":"Wanner","year":"1987","journal-title":"Kidney Int."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X05006654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X05006654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:22:58Z","timestamp":1547857378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X05006654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0041008X05006654"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2005.11.013","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}